» Articles » PMID: 34142343

Uterine Fibroids and Pregnancy: How Do They Affect Each Other?

Overview
Journal Reprod Sci
Publisher Springer
Date 2021 Jun 18
PMID 34142343
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

The present narrative review is aimed to rekindle discussion regarding whether and how uterine leiomyoma and pregnancy may impact each other. Although fibroids are hormone-dependent lesions, their growth during pregnancy seems to have a nonlinear trend. Besides placental estrogens and progesterone, an array of endocrine and paracrine factors affect fibroid blood supply, growth rate, and risk of degeneration along the gestational and puerperal periods. According to current evidence, the presence of leiomyomas might increase the risk of some adverse pregnancy outcomes. Although a causative relation between fibroids and spontaneous abortion is questionable, the presence of multiple submucosal lesions in certain populations, such as infertile women, may increase the risk of pregnancy loss. Slightly increased risks of placenta previa, placental abruption and fetal malpresentation may occur, mainly due to the mechanical influence of multiple and large fibroids. Cesarean section and preterm birth rates are also probably increased in the presence of fibroids. The risk associations are based on meta-analyses of cohort studies (level of evidence 2a), retrospective cohort studies (2b), case-control (3a), and cross-sectional studies (3b), but with a predominantly low risk of bias. For evaluating the growth pattern of leiomyomas and their real influence on obstetric outcomes, future studies should enroll women with fibroids diagnosed prior to pregnancy and follow them prospectively throughout the gestation and puerperium.

Citing Articles

The Association Between Physical Activity and Uterine Leiomyoma and Its Symptoms: A Systematic Review and Meta-Analysis.

Birolim M, Souza S, Rodrigues R, da Silva D, Martinez-Vizcaino V, Mesas A Health Sci Rep. 2025; 8(2):e70487.

PMID: 39995801 PMC: 11847712. DOI: 10.1002/hsr2.70487.


Factors, pregnancy outcomes, and management associated with non-reportable results in prenatal cell-free DNA testing.

Yin H, Wang J, Wu X, Miao M, Wang Y, Shi J Arch Gynecol Obstet. 2025; .

PMID: 39966114 DOI: 10.1007/s00404-025-07977-w.


Genetic association of lipid and lipid-lowing drug targets with uterine fibroids.

Wu M, Lin Q, Li S, Wang H, Zhou W Heliyon. 2025; 11(1):e41539.

PMID: 39844969 PMC: 11750556. DOI: 10.1016/j.heliyon.2024.e41539.


The Impact of a Huge Fibroid on Pregnancy: A Case Report.

Chhatwal J, Khanzada B, Kamran A Cureus. 2024; 16(10):e71688.

PMID: 39552976 PMC: 11568866. DOI: 10.7759/cureus.71688.


Innovative Management of a Giant Fibroid in Pregnancy: A Case Report.

Tanveer S, Shah T, Gul F, Ullah F, Tariq A Cureus. 2024; 16(10):e70894.

PMID: 39497893 PMC: 11534271. DOI: 10.7759/cureus.70894.


References
1.
Baird D, Dunson D, Hill M, Cousins D, Schectman J . High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003; 188(1):100-7. DOI: 10.1067/mob.2003.99. View

2.
Grube M, Neis F, Brucker S, Kommoss S, Andress J, Weiss M . Uterine Fibroids - Current Trends and Strategies. Surg Technol Int. 2019; 34:257-263. View

3.
Laughlin S, Baird D, Savitz D, Herring A, Hartmann K . Prevalence of uterine leiomyomas in the first trimester of pregnancy: an ultrasound-screening study. Obstet Gynecol. 2009; 113(3):630-635. PMC: 3384531. DOI: 10.1097/AOG.0b013e318197bbaf. View

4.
Mehine M, Kaasinen E, Makinen N, Katainen R, Kampjarvi K, Pitkanen E . Characterization of uterine leiomyomas by whole-genome sequencing. N Engl J Med. 2013; 369(1):43-53. DOI: 10.1056/NEJMoa1302736. View

5.
Reis F, Bloise E, Ortiga-Carvalho T . Hormones and pathogenesis of uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2016; 34:13-24. DOI: 10.1016/j.bpobgyn.2015.11.015. View